Regulatory Pathway for Licensing Biotherapeutics in Mexico.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 6 de octubre de 2021 Increased survival in puppies affected by Canine Parvovirus type II using...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 10 de abril de 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with...